BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, July 31, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 16, 2010
View Archived Issues
If NIH Challenges Genzyme's Patents, Does Anyone Care?
Read More
Telaprevir Looks Ever-Better, But Don't Discount Boceprevir
Read More
Money Raised By Biotech in 2010
Read More
FDA Approvals in July
Read More
Week in Review
Read More
Word on the Street
Read More
Week in Washington
Read More
Phase I Clinical Trials Update: July 2010
Read More
Phase II Clinical Trials Update: July 2010
Read More
Phase III Clinical Trials Update: July 2010
Read More
International AIDS Conference
Read More
Non-U.S. Clinical Trials & Regulatory Actions: July 2010
Read More
FDA Submissions, Approvals & Other Actions: July 2010
Read More
Stock Gainers and Losers For The Week
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More
M&A Not Meeting Gangbuster Expectations So Far This Year
At the J.P. Morgan healthcare conference in January, everyone was predicting that 2010 would be a gangbusters year for biotech mergers and acquisitions.
Read More
Money Raised Year to Date
Read More
